Literature DB >> 27028896

Longterm results of liver transplantation from donation after circulatory death.

Joris J Blok1, Olivier Detry2, Hein Putter3, Xavier Rogiers4, Robert J Porte5, Bart van Hoek6, Jacques Pirenne7, Herold J Metselaar8, Jan P Lerut9, Dirk K Ysebaert10, Valerio Lucidi11, Roberto I Troisi4, Undine Samuel12, A Claire den Dulk6, Jan Ringers1, Andries E Braat1.   

Abstract

Donation after circulatory death (DCD) liver transplantation (LT) may imply a risk for decreased graft survival, caused by posttransplantation complications such as primary nonfunction or ischemic-type biliary lesions. However, similar survival rates for DCD and donation after brain death (DBD) LT have been reported. The objective of this study is to determine the longterm outcome of DCD LT in the Eurotransplant region corrected for the Eurotransplant donor risk index (ET-DRI). Transplants performed in Belgium and the Netherlands (January 1, 2003 to December 31, 2007) in adult recipients were included. Graft failure was defined as either the date of recipient death or retransplantation whichever occurred first (death-uncensored graft survival). Mean follow-up was 7.2 years. In total, 126 DCD and 1264 DBD LTs were performed. Kaplan-Meier survival analyses showed different graft survival for DBD and DCD at 1 year (77.7% versus 74.8%, respectively; P = 0.71), 5 years (65.6% versus 54.4%, respectively; P = 0.02), and 10 years (47.3% versus 44.2%, respectively; P = 0.55; log-rank P = 0.038). Although there was an overall significant difference, the survival curves almost reach each other after 10 years, which is most likely caused by other risk factors being less in DCD livers. Patient survival was not significantly different (P = 0.59). Multivariate Cox regression analysis showed a hazard ratio of 1.7 (P < 0.001) for DCD (corrected for ET-DRI and recipient factors). First warm ischemia time (WIT), which is the time from the end of circulation until aortic cold perfusion, over 25 minutes was associated with a lower graft survival in univariate analysis of all DCD transplants (P = 0.002). In conclusion, DCD LT has an increased risk for diminished graft survival compared to DBD. There was no significant difference in patient survival. DCD allografts with a first WIT > 25 minutes have an increased risk for a decrease in graft survival. Liver Transplantation 22 1107-1114 2016 AASLD.
© 2016 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2016        PMID: 27028896     DOI: 10.1002/lt.24449

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  20 in total

Review 1.  Large-duct cholangiopathies: aetiology, diagnosis and treatment.

Authors:  Shyam Menon; Andrew Holt
Journal:  Frontline Gastroenterol       Date:  2019-01-04

2.  A novel hypothermic machine perfusion system using a LifePort Kidney Transporter for the preservation of rat liver.

Authors:  Cheng Zeng; Xiaoyan Hu; Yanfeng Wang; Xianpeng Zeng; Yan Xiong; Ling Li; Qifa Ye
Journal:  Exp Ther Med       Date:  2017-12-01       Impact factor: 2.447

3.  Hypothermic machine perfusion ameliorates inflammation during ischemia‑reperfusion injury via sirtuin‑1‑mediated deacetylation of nuclear factor‑κB p65 in rat livers donated after circulatory death.

Authors:  Cheng Zeng; Xiaoyan Hu; Weiyang He; Yanfeng Wang; Ling Li; Yan Xiong; Qifa Ye
Journal:  Mol Med Rep       Date:  2017-10-06       Impact factor: 2.952

4.  Dual hypothermic oxygenated machine perfusion in liver transplants donated after circulatory death.

Authors:  R van Rijn; N Karimian; A P M Matton; L C Burlage; A C Westerkamp; A P van den Berg; R H J de Kleine; M T de Boer; T Lisman; R J Porte
Journal:  Br J Surg       Date:  2017-04-10       Impact factor: 6.939

5.  Long-term results after transplantation of pediatric liver grafts from donation after circulatory death donors.

Authors:  Rianne van Rijn; Pieter E R Hoogland; Frank Lehner; Ernest L W van Heurn; Robert J Porte
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

6.  Hypothermic oxygenated machine perfusion reduces bile duct reperfusion injury after transplantation of donation after circulatory death livers.

Authors:  Rianne van Rijn; Otto B van Leeuwen; Alix P M Matton; Laura C Burlage; Janneke Wiersema-Buist; Marius C van den Heuvel; Ruben H J de Kleine; Marieke T de Boer; Annette S H Gouw; Robert J Porte
Journal:  Liver Transpl       Date:  2018-04-06       Impact factor: 5.799

7.  The Implications of the Shift Toward Donation After Circulatory Death in Australia.

Authors:  Janske Reiling; Elizabeth Forrest; Kim R Bridle; Laurence J Britton; Nishreen Santrampurwala; Darrell H G Crawford; Cornelis H C Dejong; Jonathan Fawcett
Journal:  Transplant Direct       Date:  2017-10-27

8.  Cell-free microRNAs as early predictors of graft viability during ex vivo normothermic machine perfusion of human donor livers.

Authors:  Alix P M Matton; Jasmijn W Selten; Henk P Roest; Jeroen de Jonge; Jan N M IJzermans; Vincent E de Meijer; Robert J Porte; Luc J W van der Laan
Journal:  Clin Transplant       Date:  2020-02-20       Impact factor: 2.863

Review 9.  Systematic Review and Meta-Analysis on the Impact of Thrombolytic Therapy in Liver Transplantation Following Donation after Circulatory Death.

Authors:  Kumar Jayant; Isabella Reccia; Francesco Virdis; A M James Shapiro
Journal:  J Clin Med       Date:  2018-11-08       Impact factor: 4.241

Review 10.  The Immunological Basis of Liver Allograft Rejection.

Authors:  Vincenzo Ronca; Grace Wootton; Chiara Milani; Owen Cain
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.